Renaissance Technologies
COCH icon

Renaissance Technologies’s Envoy Medical COCH Stock Holding History

Renaissance Technologies’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,555
Closed -$41K – 3551
2024
Q1 		$41K Buy
+10,555
New +$30.9K ﹤0.01% 3508

Other funds holding COCH

AMC
Atlas Merchant Capital New York $585K AUM 83.95% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return

Renaissance Technologies's COCH Position: Q2 2024 in Review

Renaissance Technologies sold out of Envoy Medical (COCH) in Q2 2024, closing a stake of 10,555 shares — an estimated $41K sold.

Renaissance Technologies first reported a position in COCH in Q1 2024 and held it in 1 quarter. The position peaked at $41K in Q1 2024. 20 funds tracked by Wall St. Rank hold COCH as of Q2 2024.

  • Renaissance Technologies reported no remaining Envoy Medical position as of Q2 2024 after selling out during the quarter.
  • Renaissance Technologies sold 10,555 Envoy Medical shares in Q2 2024, an estimated $41K.
  • Renaissance Technologies first reported a position in Envoy Medical in Q1 2024 and held it in 1 quarter.
  • Renaissance Technologies's Envoy Medical position peaked at $41K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Envoy Medical as of Q2 2024.

Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.